Breaking News Instant updates and real-time market news.

NUVA

NuVasive

$61.01

0.09 (0.15%)

08:37
01/08/18
01/08
08:37
01/08/18
08:37

NuVasive sees FY18 revenue growth in 'mid-single digits over FY17'

Consensus $1.09B. The company's preliminary outlook for 2018 includes full year revenue growth in the mid-single digits over 2017 revenue results, at least 100 basis points of expansion in non-GAAP operating margin, adjusted EBITDA now in a range of approximately $290 to $300 million, and a substantial tax savings resulting from the tax reform legislation passed late in 2017. When the company provides its full financial outlook for 2018, it will include the expected financial impact of the company's acquisition of SafePassage. In Dec. 2017, NuVasive announced it had entered into an agreement to acquire SafePassage to bolster its NuVasive Clinical Services business and solidify its leadership position as the largest provider of outsourced intraoperative neuromonitoring services. This joining of forces will strengthen the NuVasive IONM business line with more than 550 neurophysiologists and oversight physicians in the U.S.-allowing for the delivery of services to over 1,000 customers and 3,000 surgeons. The acquisition of SafePassage remains on track and is anticipated to close in Jan. 2018, subject to customary closing conditions. The company will also provide additional commentary on the expected impact of U.S. tax reform. NuVasive expects to realize substantial tax savings as a result of the recent passage of the tax bill, An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018, which provides for a reduction of the U.S. corporate tax rate from 35% to approximately 21%. The legislation is poised to significantly reduce the future corporate tax rate for NuVasive, which prior to the enactment of the tax overhaul was expected to be approximately 33% on a non-GAAP basis in 2018.

  • 08

    Jan

NUVA NuVasive
$61.01

0.09 (0.15%)

12/15/17
PIPR
12/15/17
NO CHANGE
Target $90
PIPR
Overweight
NuVasive's new lateral ALIF system underappreciated, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien views NuVasive's new lateral anterior lumbar interbody fusion procedure as an underappreciated revenue driver for the company. This as an important introduction for NuVasive as it finally allows the company to access the lower lumbar region with less invasiveness, O'Brien tells investors in a research note. He notes the product will allow NuVasive to compete head-to-head with Medtronic's (MDT) OLIF procedure, which he believes has grown quickly. O'Brien sees the lateral ALIF system adding $30M-$50M to NuVasive sales over the next three to four years, helping to push the stock higher. He keeps an Overweight rating on the stock with a $90 price target.
12/21/17
JPMS
12/21/17
NO CHANGE
JPMS
Overweight
NuVasive among biggest beneficiaries in MedTech from tax reform, says JPMorgan
JPMorgan analyst Robbie Marcus noted that NuVasive announced that it estimates tax law changes should drop its non-GAAP tax rate into the "low 20% range" in 2018, which he said makes it one of the biggest beneficiaries in the MedTech sector from U.S. tax reform. However, he also thinks the tax benefits have been well telegraphed and that much of the expected benefit is already factored into the stock. He maintains an Overweight rating on NuVasive shares.
12/28/17
PIPR
12/28/17
NO CHANGE
PIPR
Piper says own K2M, NuVasive into January conference
Piper Jaffray analyst Matt O'Brien recommends owning shares of K2M Group (KTWO) and NuVasive (NUVA) into a competitor conference that begins on January 8. The analyst is cautious on Zimmer Biomet (ZBH) into the conference. K2M and NuVasive are names to own going into the conference as both will meet or beat Q4 revenue estimates, O'Brien tells investors in a research note. He sees a favorable 2018 outlook for both companies as well as room for multiple expansion. On Zimmer, which the analyst downgraded recently, O'Brien continues to believe the company's turnaround will take longer than investors realize.
01/04/18
NEED
01/04/18
UPGRADE
Target $71
NEED
Buy
NuVasive upgraded to Buy from Underperform at Needham
As reported earlier, Needham analyst Mike Matson upgraded NuVasive two notches, to Buy from Underperform, and set a $71 price target on the shares. Matson says consensus revenue and EPS estimates have declined to more realistic and "likely conservative" levels, while the company's acquisitions of Vertera and SafePassage are likely not factored into consensus. The analyst also expects a 15% increase in NuVasive EPS as a result of the "significant benefit" from lower U.S. corporate tax rates.

TODAY'S FREE FLY STORIES

SPY

SPDR S&P 500 ETF Trust

$272.57

-0.69 (-0.25%)

, SPX

S&P 500

$0.00

(0.00%)

21:05
05/22/18
05/22
21:05
05/22/18
21:05
Periodicals
Trump to propose further tax cuts before November, Reuters reports »

President Trump has…

SPY

SPDR S&P 500 ETF Trust

$272.57

-0.69 (-0.25%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBK

FB Financial

$42.26

-1.36 (-3.12%)

20:49
05/22/18
05/22
20:49
05/22/18
20:49
Syndicate
FB Financial 3.2M share Secondary priced at $41.25 »

JPMorgan and Stephens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 24

    Sep

  • 23

    May

MYOK

MyoKardia

$50.45

2.15 (4.45%)

20:48
05/22/18
05/22
20:48
05/22/18
20:48
Syndicate
MyoKardia 3.75M share Secondary priced at $49.00 »

JPMorgan, BofA/Merrill,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

TWOU

2U

$91.64

-3.86 (-4.04%)

20:47
05/22/18
05/22
20:47
05/22/18
20:47
Syndicate
2U 3.3M share Secondary priced at $90.00 »

Goldman Sachs and Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

ARDX

Ardelyx

$4.50

-1.15 (-20.35%)

20:46
05/22/18
05/22
20:46
05/22/18
20:46
Syndicate
Ardelyx 12.5M share Secondary priced at $4.00 »

Jefferies and Leerink…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

  • 23

    May

LOW

Lowe's

$85.74

-1.63 (-1.87%)

, TGT

Target

$75.42

-1.44 (-1.87%)

20:25
05/22/18
05/22
20:25
05/22/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

LOW

Lowe's

$85.74

-1.63 (-1.87%)

TGT

Target

$75.42

-1.44 (-1.87%)

TIF

Tiffany

$102.26

-0.96 (-0.93%)

RL

Ralph Lauren

$116.67

-0.41 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 24

    May

  • 07

    Jun

  • 19

    Jun

  • 26

    Jun

INFO

IHS Markit

$51.28

-0.32 (-0.62%)

20:02
05/22/18
05/22
20:02
05/22/18
20:02
Hot Stocks
IHS Markit expands MarkitSERV trade reporting solution in Asia and Europe »

IHS Markit (INFO)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDAY

Ceridian

$34.31

-0.885 (-2.51%)

19:54
05/22/18
05/22
19:54
05/22/18
19:54
Recommendations
Ceridian analyst commentary  »

Ceridian price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

RMTI

Rockwell Medical

$5.94

-0.06 (-1.00%)

19:20
05/22/18
05/22
19:20
05/22/18
19:20
Hot Stocks
Rockwell Medical president, CEO Chioini terminated from his positions »

Rockwell Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,582.10

-3.45 (-0.22%)

19:16
05/22/18
05/22
19:16
05/22/18
19:16
Periodicals
Amazon.com has banned some shoppers who make excessive returns, WSJ says »

Amazon.com has banned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

CTRP

Ctrip

$43.46

0.48 (1.12%)

, HPE

HP Enterprise

$17.49

-0.01 (-0.06%)

19:03
05/22/18
05/22
19:03
05/22/18
19:03
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Ctrip…

CTRP

Ctrip

$43.46

0.48 (1.12%)

HPE

HP Enterprise

$17.49

-0.01 (-0.06%)

ARCO

Arcos Dorados

$7.55

0.35 (4.86%)

MET

MetLife

$48.48

0.405 (0.84%)

RRGB

Red Robin

$57.80

-2.9 (-4.78%)

TCS

Container Store

$8.23

0.68 (9.01%)

URBN

Urban Outfitters

$41.21

-1.09 (-2.58%)

CRIS

Curis

$0.53

0.0211 (4.13%)

IBTX

Independent Bank

$77.85

-0.7 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 30

    May

  • 05

    Jun

  • 11

    Jun

  • 12

    Jun

  • 10

    Jul

  • 10

    Sep

  • 24

    Sep

EADSY

Airbus

$0.00

(0.00%)

, BA

Boeing

$355.06

-8.89 (-2.44%)

18:59
05/22/18
05/22
18:59
05/22/18
18:59
Periodicals
Airbus says plane subsidies over, U.S. rejects notion, WSJ says »

The U.S. and EU have…

EADSY

Airbus

$0.00

(0.00%)

BA

Boeing

$355.06

-8.89 (-2.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

QTNA

Quantenna Communications

$14.94

-0.13 (-0.86%)

18:43
05/22/18
05/22
18:43
05/22/18
18:43
Initiation
Quantenna Communications initiated at William Blair »

Quantenna assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

ALGT

Allegiant Travel

$153.95

-5.15 (-3.24%)

18:42
05/22/18
05/22
18:42
05/22/18
18:42
Hot Stocks
Allegiant Travel announces tentative dispatchers contract agreement with IBT »

Allegiant announces that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

EA

Electronic Arts

$132.18

-0.73 (-0.55%)

18:30
05/22/18
05/22
18:30
05/22/18
18:30
Recommendations
Electronic Arts analyst commentary at Baird »

Electronic Arts'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POOL

Pool Corp.

$145.96

-3.74 (-2.50%)

18:22
05/22/18
05/22
18:22
05/22/18
18:22
Hot Stocks
Pool Corp. director Stokely sells 10,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

  • 13

    Jun

RRGB

Red Robin

$57.80

-2.9 (-4.78%)

18:16
05/22/18
05/22
18:16
05/22/18
18:16
Recommendations
Red Robin analyst commentary at Stephens »

Red Robin Q1 traffic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

BGS

B&G Foods

$26.50

-0.75 (-2.75%)

18:11
05/22/18
05/22
18:11
05/22/18
18:11
Hot Stocks
B&G Foods increases dividend 2.2% to 47.5c »

B&G Foods announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

CTRP

Ctrip

$43.46

0.48 (1.12%)

18:05
05/22/18
05/22
18:05
05/22/18
18:05
Hot Stocks
Breaking Hot Stocks news story on Ctrip »

Ctrip falls over 3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

CTRP

Ctrip

$43.46

0.48 (1.12%)

18:05
05/22/18
05/22
18:05
05/22/18
18:05
Earnings
Ctrip reports Q1 adjusted earnings per ADS 55c, may not compare to consensus 16c »

Reports Q1 revenue $1.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

PLBC

Plumas Bancorp

$28.00

(0.00%)

18:02
05/22/18
05/22
18:02
05/22/18
18:02
Hot Stocks
Plumas Bank agrees to purchase Carson City branch of Mutual of Omaha Bank »

Plumas Bank, the wholly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRP

Ctrip

$43.46

0.48 (1.12%)

18:02
05/22/18
05/22
18:02
05/22/18
18:02
Earnings
Breaking Earnings news story on Ctrip »

Ctrip sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

CRIS

Curis

$0.53

0.0211 (4.13%)

17:56
05/22/18
05/22
17:56
05/22/18
17:56
Hot Stocks
Curis announces 1-for-5 reverse stock split »

Curis announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCS

Container Store

$8.23

0.68 (9.01%)

17:47
05/22/18
05/22
17:47
05/22/18
17:47
Hot Stocks
Container Store drops 12% after Q4 EPS lower than estimates »

Shares of the Container…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

URBN

Urban Outfitters

$41.21

-1.09 (-2.58%)

17:45
05/22/18
05/22
17:45
05/22/18
17:45
Hot Stocks
Urban Outfitters sees Q2 SSS so far stronger than Q1 »

Comment taken from Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.